Precision MedicineNCT07704593
Preliminary Effectiveness of Process-Based Personalized Physiotherapy for (Sub)Acute Neck Pain
A study testing Personalized physiotherapy grounded in the PBT framework in people with Precision Medicine, run by University of Applied Sciences Utrecht at 9 sites in Netherlands.
Trial summary
The goal of this clinical trial is to learn if personalized physiotherapy can lower neck pain in adults with recent (sub)acute neck pain who have a higher chance of the pain becoming long-lasting. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Precision Medicine
- What is being tested?
- Personalized physiotherapy grounded in the PBT framework
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 11 participants
- Where
- 9 sitesNetherlands
- Study dates
- 1 Aug 2026to 31 Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 18 years or older
- New episode of neck pain with duration ≤12 weeks since onset
- Neck pain located in the region shown in Figure 2
- ≥19% risk of developing chronic complaints, as determined using a prognostic model
- If a previous episode of neck pain occurred, the current episode must have been preceded by ≥3 consecutive months without persistent pain (defined as absence of pain associated with activity limitation or healthcare consultation)
Who cannot join
- Prior neck surgery
- Cervical radiculopathy as identified using the Upper Limb Neurodynamic Test (ULNT1)
- Widespread primary pain according to ICD-11 criteria (diffuse musculoskeletal pain in ≥4 of 5 body regions, across ≥3 body quadrants, involving the axial skeleton)
- Pain of non-musculoskeletal origin
- Insufficient proficiency in Dutch to read or understand study instructions
Trial locations and contacts
9 sites in 1 country. Contact the study team or a site near you to ask about taking part.
9 sites in 1 country
Netherlands9 sites
Douglas Fysiotherapie & Sport
Alphen aan den Rijn, South Holland, 2401 PR
Martine van der Lijn-Helder, MSc, 0031172420503, info@douglas-fysiotherapie.nl
Praktijk Boshuijzen Manuele therapie
Amersfoort, Utrecht, 3817 VB
Arjan Boshuijzen, MSc, 0031639608038, info@praktijkboshuijzen.nl
FS Fysio
Capelle aan den IJssel, South Holland, 2909 VA
Jasper Bier, Dr., 003110288 11 28, fascinatio@fsfysio.nl
Lijfkracht Fysiotherapie
Drachten, Provincie Friesland, 9202 PD
Tineke Pieterson, MSc, 0031512745142, info@lijfkrachtfysiotherapie.nl
Expertisecentrum Fysiotherapie
Groningen, Provincie Groningen, 9713 CA
Sander Ensing, MSc, 0503604573, info@expertisecentrumfysiotherapie.nl
Fysio-Experts
Hazerswoude-Rijndijk, South Holland, 2394 AG
Sjoerd Morsink, BSc, 0031640 975 375, info@fysio-experts.nl
Medifit Oss
Oss, North Brabant, 5345 SC
Marc van den Berg, MSc, 0031412636234, info@medifitoss.nl
Fysio- Manuele Therapie Lutke Schipholt c.s.
Tilburg, North Brabant, 5046 DA
Ivo Lutke Schipholt, Dr., 0031613792651, i.j.m.lutkeschipholt@vu.nl
Fysiotherapeutisch centrum Palenstein
Zoetermeer, South Holland, 2722 RX
Markwin van Veelen, MSc, 00317933 14 293, info@fysiopalenstein.nl
About this study
Official title: The Preliminary Effectiveness of Personalized Physiotherapy Grounded in a Process-Based Therapy Framework in People With (Sub)Acute Neck Pain: a Protocol for a Mixed-methods Single-case Research Design
The goal of this clinical trial is to learn if personalized physiotherapy can lower neck pain in adults with recent (sub)acute neck pain who have a higher chance of the pain becoming long-lasting. The main questions it aims to answer are:
Does personalized physiotherapy lower pain compared to standard physiotherapy? Does personalized physiotherapy improve daily activities, quality of life, and pain interference compared to standard physiotherapy? Do physiotherapists deliver the personalized treatment as intended?
Read more
Researchers will compare each participant's own results during a standard care period to their results during a personalized care period, to see if the personalized approach works better than standard care.
Participants will:
Receive standard physiotherapy care for 3 weeks Then receive personalized physiotherapy, tailored to their individual needs, for several weeks (until their treatment goals are achieved) Answer short questions about their pain and daily functioning three times a week Take part in an interview about their experiences every 3 weeks
Read the detailed description
This study employs a replicated mixed-methods single-case experimental design (MMSCR) with a convergent, parallel approach, in which quantitative and qualitative data are collected concurrently and subsequently integrated. The protocol was developed in accordance with the Single-Case Reporting Guideline in Behavioural Interventions (SCRIBE) 2016 and the Mixed Methods Reporting in Rehabilitation \& Health Sciences (MMR-RHS) guidelines.
Rationale Non-specific neck pain (NSNP) is a multifactorial condition in which physical, behavioral, cognitive, and contextual processes vary between patients, change over time, and continuously interact. A standardized treatment approach is therefore inherently limited. Personalized physiotherapy grounded in a Process-Based Therapy (PBT) framework aims to address this by continuously identifying which modifiable biopsychosocial processes are most relevant for an individual patient at a given moment, and selecting interventions that most efficiently target those processes. To make this approach feasible in daily primary care practice, a treatment protocol was developed together with a data-driven Clinical Compass, consisting of clinical indicators of modifiable biopsychosocial processes. This study is designed to obtain a first estimate of the preliminary effectiveness of this approach and to examine the fidelity with which it is delivered, prior to larger-scale evaluation.
Study design The quantitative component follows a nonconcurrent AB single-case experimental design (SCED) with repeated measurement, replicated systematically across 11 participants (11 SCEDs). Each participant undergoes a predetermined phase sequence: a baseline phase (A) followed by an intervention phase (B). The baseline phase spans three weeks with a minimum of nine measurement points; the intervention phase lasts a minimum of two weeks with a minimum of six measurement points, with actual duration depending on individual treatment progress. The number of measurements per phase was determined based on the discriminative power required to detect changes in outcome trajectories. Replication across 11 cases is achieved by delivering the intervention through different physiotherapists working in different geographic regions, all applying identical eligibility criteria.
Researcher blinding is not applied, as outcome measures are self-reported and the researcher is not involved in intervention delivery.
Study setting and therapist training The study will be conducted in nine primary care physiotherapy practices participating in the project consortium, purposefully selected to ensure variation in demographic characteristics, specialization, and practice size. Prior to study commencement, all participating physiotherapists complete a structured training programme targeting knowledge transfer, skill development, professional identity, and behavior change in practice. The programme consists of four sequential components: preparatory video modules with personal reflection, an online interactive case-based session, a live training session including role-play with a trained actor and guided reflection, and structured peer supervision sessions during the active treatment phase of the study to support implementation.
Baseline phase (Phase A) During the three-week baseline phase, participants receive standard care consisting of an intake and two treatment sessions in accordance with the Royal Dutch Society for Physical Therapy (KNGF) Clinical Practice Guideline for Neck Pain. During this phase, the physiotherapist delivers usual care without access to Clinical Compass results and without structured insight into the participant's modifiable biopsychosocial processes. Based on prior research in this population, an average reduction in pain intensity of approximately 35-45% is expected during the first six weeks due to standard care and spontaneous recovery. This anticipated recovery trajectory is explicitly modelled in the analysis, enabling differentiation between changes consistent with natural recovery or standard care and changes potentially attributable to the personalized intervention introduced in Phase B. All clinical activities during this phase are documented in the Electronic Health Record (EHR) to allow retrospective analysis.
Intervention phase (Phase B) During the intervention phase, treatment is continuously adapted to the modifiable biopsychosocial process(es) identified as most relevant, jointly mapped and evaluated with the patient throughout the treatment trajectory. Intervention sequencing is process-driven rather than time-driven. The approach follows five sequential steps: (1) joint identification of modifiable biopsychosocial processes using the Clinical Compass, a structured biopsychosocial anamnesis, and physical examination where relevant; (2) construction of a person-specific network model in which goals, problems, limitations, and influencing factors are represented as interconnected nodes, including feedback loops that may maintain the patient's complaints; (3) shared decision-making to prioritize the most central modifiable process, guided by six criteria (accessibility, centrality, therapist competence, risk, likelihood of change, and strategic positioning); (4) delivery of personalized interventions targeting the selected process, guided by a consensus-based framework linking processes to evidence-based intervention components within the physiotherapy domain, developed through a modified Delphi study among primary care physiotherapy experts; and (5) ongoing monitoring and adjustment, in which each session begins with shared reflection on changes in the targeted process, experiences in daily life, and barriers or facilitators, informing the decision to continue, adapt, or shift the intervention focus.
Treatment duration and frequency are tailored to the individual patient's goals and presenting problems. The intervention concludes once agreed treatment goals are achieved, or if no improvement occurs after six weeks; this decision is explicitly discussed with the patient beforehand. Participants may continue to receive any other usual care they would otherwise receive during the study.
Data collection In parallel with quantitative monitoring, two additional qualitative data sources are collected: semi-structured interviews conducted with participants every three weeks to explore their experienced change and treatment attribution, and session data comprising audio recordings of treatment sessions together with session-level data extracted from the EHR.
Fidelity assessment Intervention fidelity is assessed using three complementary approaches, all based on audio recordings and/or EHR data: (1) a global rating of intervention delivery during the B-phase, based on a purpose-developed rating scale assessing the presence of core PBT elements, the absence of inappropriate elements, and quality of execution; (2) a parallel global rating applied to baseline-phase recordings to confirm the expected absence of PBT-consistent delivery during standard care, supporting intervention differentiation; and (3) a qualitative, deductive analysis of EHR session data examining the sequence, content, and rationale of delivered intervention components, and how these align with patient characteristics and adjustments made over the treatment trajectory. A minimum of 20% of sessions per participant will be reviewed. Two trained raters, blinded to treatment phase, will independently code recordings after a calibration period; inter-rater reliability will be calculated using an intraclass correlation coefficient. Fidelity results are not fed back to physiotherapists during the study.
Data analysis
Quantitative analysis: Individual and cross-participant effects are evaluated using visual analysis (following the Visual Aid Implying an Objective Rule, VAIOR) complemented by multivariate piecewise linear regression, consistent with established SCED analytic approaches. Because the intervention is expected to produce a delayed or progressive rather than immediate effect, visual analysis focuses primarily on the final measurements of the intervention phase. Improvement direction is predefined for each outcome domain prior to analysis. Consistency of effects across the 11 replications is evaluated against a predefined replication criterion (a positive effect in at least 8 of 11 cases). Two trained researchers conduct visual analyses independently, with inter-rater reliability reported.
Participants who complete the baseline phase and at least two weeks of the intervention phase are included in the analysis; missing data are handled using the Expectation-Maximization algorithm.
Sample size was informed by an a priori power analysis for SCED designs, based on a conservative effect size estimate derived from comparable prior research in the same population, and will be re-evaluated after the first five participants.
Qualitative analysis: Interview transcripts are analyzed using descriptive open coding within three predefined analytical domains: experienced change, the relationship between experience and intervention, and the relationship between experience and quantitative measurements. Analysis is conducted independently by two researchers with consensus meetings to resolve differences, supported by peer debriefing from a third researcher not involved in data collection. A narrative pattern description is developed for each participant, and an audit trail and reflexive memos are maintained throughout.
Integration: For each participant, quantitative outcome trajectories (level, trend, and variability) are systematically compared with the qualitative pattern description through triangulation, assessing congruence, divergence, and complementarity to arrive at individual-level meta-inferences.
A cross-case overview subsequently compares all 11 cases on quantitative pattern, experienced trajectory, congruence/divergence, treatment attribution, fidelity scores, and intervention content and sequence, aiming to identify recurring patterns, explanatory variation between cases, and potential subgroups.
- Conditions
- Precision Medicine
- Being tested
- Personalized physiotherapy grounded in the PBT framework
- Keywords
- Neck Pain, Physical Therapy, Single-Case Studies as Topic
- Medical subject headings
- Neck Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Personalized physiotherapy grounded in the PBT frameworkBehavioural
During the intervention phase (B-phase), treatment follows the steps of personalized physiotherapy grounded in a PBT framework. Treatment is continuously adapted to the identified and prioritized modifiable biopsychosocial process, as jointly mapped and evaluated with the patient throughout the treatment trajectory. Intervention sequencing is not time-driven but process-driven, with session-by-session evaluation guiding when to continue, adapt, or shift intervention targets. The identification and ongoing evaluation of relevant processes is informed by the Clinical Compass and, where indicated, supplemented with one or more items from the supplementary item pool. Assessment is guided by a structured biopsychosocial evaluation using the SCEGS framework (Somatic, Cognitive, Emotional, Behavioral, Social), which supports systematic exploration of somatic symptoms, cognitions, emotions, behaviors, and social context to identify modifiable processes.
| Study group | Role | What they receive |
|---|---|---|
| Phase A: Baseline conditions | Experimental | During the three-week baseline phase (A), participants will receive standard care, consisting of an intake and two treatment sessions in accordance with the KNGF Clinical Practice Guideline for Neck Pain. Diagnostic procedures will include anamnesis (screening for red flags, classification of neck pain, assessment of symptom characteristics and interference with daily functioning based on the International Classification of Functioning (ICF), as well as symptom course and onset), optionally supplemented with physical examination.
Standard care interventions will be delivered according to treatment profile and may include education and advice, mobilizations, and exercise therapy.
During the baseline phase, the physiotherapist will deliver usual care without access to the Clinical Compass results and therefore without structured insight into the participant's potentially modifiable biopsychosocial processes targeted in the intervention phase. Receives: Behavioral: Personalized physiotherapy grounded in the PBT framework |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain intensity
Pain intensity will be measured using an 11-point Numeric Pain Rating Scale (NPRS). Patients will answer the question: "How intense was your pain on average over the past two days?" Responses range from 0 = no pain to 10 = worst imaginable pain. The NPRS is a validated instrument recommended in the Royal Dutch Society for Physical Therapy (KNGF) Neck Pain Guideline for evaluating pain intensity. The Minimal Important Change (MIC) for patients with neck pain is 2.5 points.
Measured: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Secondary outcomes (9)
Patient-specific activity limitations
Patient-specific activity limitations will be measured with the Patient Specific Functional Scale (PSFS). For each patient, three personally relevant activities will be selected, each linked to a specific goal (e.g., "working 20 minutes at the computer" rather than "computer work"). For each activity, participants will answer: "How difficult was it for you to perform this activity over the past two days?". Responses range from 0 = no difficulty to 10 = impossible to perform the activity. The PSFS is a validated evaluative instrument recommended for patients with NSNP with a MIC of 2.7 points in people with NSNP.
Measured: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Pain coping
Pain coping will be measured using the Pain Coping Inventory (PCI). The PCI is a 33-item self-report questionnaire that assesses how patients cope with pain. Patients rate how often they use different coping strategies on a 4-point Likert scale ranging from 1 = rarely or never to 4 = very often. The questionnaire comprises six subscales: pain transformation, distraction, reducing demands, retreating, worrying, and resting. These subscales are grouped into two higher-order dimensions: active pain coping (pain transformation, distraction, reducing demands) and passive pain coping (retreating, worrying, resting). Higher scores indicate more frequent use of the corresponding coping strategies. The PCI is a valid and reliable instrument for assessing pain coping in patients with chronic pain.
Measured: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Quality of Life as Measured by EQ-5D-VAS
Quality of life will be assessed using the Visual Analogue Scale of the EQ-5D (EQ-5D-VAS). Participants will answer: "How good or bad was your health over the past two days?" The vertical VAS ranges from 0 = worst imaginable health to 100 = best imaginable health. The EQ-5D-VAS demonstrates good practical usability and moderate to good reliability in Dutch populations. No MIC has been established for NSNP.
Measured: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Pain interference
Pain interference will be measured using the Interference scale of the Brief Pain Inventory Short Form (BPI-SF). Patients will rate the extent to which pain interfered with daily activities by answering: "To what extent has pain interfered with the following aspects of your life during the past 24 hours?" Each domain is scored from 0 = no interference to 10 = complete interference. Domains include: mood, enjoyment of life, relationships with others, sleep, general activity, walking ability, and work. Scores are calculated as the mean of at least four completed items. A Dutch translation is available. The interference scale demonstrates good psychometric properties in musculoskeletal pain conditions. No MIC is established for NSNP.
Measured: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Perceived effect
Perceived effect will be measured using the Global Perceived Effect (GPE) scale, which is recommended as an outcome measure for NSNP. Patients will answer the following question: "To what extent have your complaints changed since the start of treatment?" Responses are scored on a 7-point scale ranging from 1 = very much improved to 7 = very much worse. The GPE captures the patient's perception of change attributed to the intervention and is considered a reliable self-report measure of treatment effect. Since the GPE is a global measure that may reflect changes across multiple underlying domains, an additional question will be included: "What did you consider when answering that question?" Response options are: (a) neck symptoms, (b) neck movement (biomechanical performance), (c) activities of daily living, (d) greater control over the complaint (self-efficacy), and (e) change due to another intervention
Measured: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Fear of movement
Fear of movement will be measured using the 11-item Tampa Scale for Kinesiophobia (TSK-11). The TSK-11 is a self-report questionnaire that assesses fear of movement and fear of (re)injury associated with pain. Patients rate 11 statements on a 4-point Likert scale ranging from 1 = strongly disagree to 4 = strongly agree. Total scores range from 11 to 44, with higher scores indicating greater fear of movement. The TSK-11 is a shortened version of the original Tampa Scale for Kinesiophobia and has demonstrated good internal consistency, test-retest reliability, responsiveness, and concurrent and predictive validity in patients with chronic pain.
Measured: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Hypervigilance
Hypervigilance will be measured using the Pain Vigilance and Awareness Questionnaire (PVAQ). The PVAQ is a 16-item self-report questionnaire that assesses the extent to which patients attend to and monitor their pain. Patients are asked to consider their behaviour over the past two weeks and rate each item on a 6-point Likert scale ranging from 0 = never to 5 = always. Total scores are calculated by summing the item scores, with higher scores indicating greater pain vigilance and awareness. The PVAQ has demonstrated good internal consistency, construct validity, and convergent validity in patients with chronic pain.
Measured: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Sleep
Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-report questionnaire that assesses subjective sleep quality over the previous month. It consists of 19 self-rated items, which are combined into seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. These component scores are summed to obtain a global score ranging from 0 to 21, with higher scores indicating poorer sleep quality. The PSQI has demonstrated good internal consistency, excellent test-retest reliability, and good validity in patients with sleep disorders.
Measured: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Pain catastrophizing
Catastrophizing Scale (PCS-6). The PCS-6 is a brief self-report questionnaire that assesses the extent to which patients experience catastrophic thoughts and feelings in response to pain. Patients rate the frequency of each statement on a 5-point Likert scale ranging from 0 = not at all to 4 = all the time. Item scores are summed to obtain a total score, with higher scores indicating greater levels of pain catastrophizing. The PCS-6 has demonstrated good reliability and validity.
Measured: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2026
- Study start1 Aug 2026 (estimated)
- Primary completion31 Jul 2027 (estimated)
- Study completion31 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Precision MedicineStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The study will employ a replicated MMSCR with a convergent, parallel, mixed methods approach, in which quantitative and qualitative data will be collected concurrently and subsequently integrated. The quantitative component follows a nonconcurrent AB SCED structure with repeated measurement. Each participant undergoes a baseline phase (A) with standard care, followed by an intervention phase (B) of personalized physiotherapy grounded in a PBT framework. The phase sequence is predetermined: the baseline phase spans three weeks with a minimum of nine measurement points, and the intervention phase lasts at least 2 weeks with a minimum of six measurement points. The number of measurements per phase is based on the required discriminative power to detect changes in the trajectory of outcome variables. Intervention phase duration is patient-dependent; given the target population and average treatment episode length for NSNP, a longer phase is expected.
- Masking
- None (open label)
- Enrolment
- 11 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Applied Sciences Utrecht
- Sponsor type
- University, hospital or other
- Collaborators
- Maastricht University
- Responsible party
- Principal investigator, Sophie Konings, University of Applied Sciences Utrecht
- Investigators
- Sophie Konings, MSc, Principal investigator, University of Applied Sciences Utrecht
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07704593
- Sponsor's protocol ID
- 354-003-2026
- Other IDs
- RAAK.MKB21.010
- Status last verified
- Jul 2026
- First submitted
- 3 Jul 2026
- Last updated
- 15 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: After study completion, de-identified quantitative participant data and associated statistical code will be made available via DataverseNL. Data will be anonymized and reviewed by a data steward prior to sharing, in accordance with FAIR principles and applicable data protection regulations. Access restrictions may apply where necessary to protect participant privacy. Qualitative data (interview transcripts and audio recordings) will not be shared publicly due to the risk of participant re-identification.
Study at a glance
From the registry record, last updated by the sponsor on 15 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Preliminary Effectiveness of Personalized Physiotherapy Grounded in a Process-Based Therapy Framework in People With (Sub)Acute Neck Pain: a Protocol for a Mixed-methods Single-case Research Design
- ClinicalTrials.gov ID
- NCT07704593
- Acronym / sponsor ID
- 354-003-2026
- Conditions
- Precision Medicine
- Keywords
- Neck Pain, Physical Therapy, Single-Case Studies as Topic
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 11 participants (estimated)
- Lead sponsor
- University of Applied Sciences UtrechtUniversity, hospital or other
- Collaborators
- Maastricht University
- Study start
- 1 Aug 2026 (estimated)
- Primary completion
- 31 Jul 2027 (estimated)
- Study completion
- 31 Jul 2027 (estimated)
- First posted
- 15 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if personalized physiotherapy can lower neck pain in adults with recent (sub)acute neck pain who have a higher chance of the pain becoming long-lasting. The main questions it aims to answer are:
Does personalized physiotherapy lower pain compared to standard physiotherapy? Does personalized physiotherapy improve daily activities, quality of life, and pain interference compared to standard physiotherapy? Do physiotherapists deliver the personalized treatment as intended?
Researchers will compare each participant's own results during a standard care period to their results during a personalized care period, to see if the personalized approach works better than standard care.
Participants will:
Receive standard physiotherapy care for 3 weeks Then receive personalized physiotherapy, tailored to their individual needs, for several weeks (until their treatment goals are achieved) Answer short questions about their pain and daily functioning three times a week Take part in an interview about their experiences every 3 weeks
Detailed description
This study employs a replicated mixed-methods single-case experimental design (MMSCR) with a convergent, parallel approach, in which quantitative and qualitative data are collected concurrently and subsequently integrated. The protocol was developed in accordance with the Single-Case Reporting Guideline in Behavioural Interventions (SCRIBE) 2016 and the Mixed Methods Reporting in Rehabilitation \& Health Sciences (MMR-RHS) guidelines.
Rationale Non-specific neck pain (NSNP) is a multifactorial condition in which physical, behavioral, cognitive, and contextual processes vary between patients, change over time, and continuously interact. A standardized treatment approach is therefore inherently limited. Personalized physiotherapy grounded in a Process-Based Therapy (PBT) framework aims to address this by continuously identifying which modifiable biopsychosocial processes are most relevant for an individual patient at a given moment, and selecting interventions that most efficiently target those processes. To make this approach feasible in daily primary care practice, a treatment protocol was developed together with a data-driven Clinical Compass, consisting of clinical indicators of modifiable biopsychosocial processes. This study is designed to obtain a first estimate of the preliminary effectiveness of this approach and to examine the fidelity with which it is delivered, prior to larger-scale evaluation.
Study design The quantitative component follows a nonconcurrent AB single-case experimental design (SCED) with repeated measurement, replicated systematically across 11 participants (11 SCEDs). Each participant undergoes a predetermined phase sequence: a baseline phase (A) followed by an intervention phase (B). The baseline phase spans three weeks with a minimum of nine measurement points; the intervention phase lasts a minimum of two weeks with a minimum of six measurement points, with actual duration depending on individual treatment progress. The number of measurements per phase was determined based on the discriminative power required to detect changes in outcome trajectories. Replication across 11 cases is achieved by delivering the intervention through different physiotherapists working in different geographic regions, all applying identical eligibility criteria.
Researcher blinding is not applied, as outcome measures are self-reported and the researcher is not involved in intervention delivery.
Study setting and therapist training The study will be conducted in nine primary care physiotherapy practices participating in the project consortium, purposefully selected to ensure variation in demographic characteristics, specialization, and practice size. Prior to study commencement, all participating physiotherapists complete a structured training programme targeting knowledge transfer, skill development, professional identity, and behavior change in practice. The programme consists of four sequential components: preparatory video modules with personal reflection, an online interactive case-based session, a live training session including role-play with a trained actor and guided reflection, and structured peer supervision sessions during the active treatment phase of the study to support implementation.
Baseline phase (Phase A) During the three-week baseline phase, participants receive standard care consisting of an intake and two treatment sessions in accordance with the Royal Dutch Society for Physical Therapy (KNGF) Clinical Practice Guideline for Neck Pain. During this phase, the physiotherapist delivers usual care without access to Clinical Compass results and without structured insight into the participant's modifiable biopsychosocial processes. Based on prior research in this population, an average reduction in pain intensity of approximately 35-45% is expected during the first six weeks due to standard care and spontaneous recovery. This anticipated recovery trajectory is explicitly modelled in the analysis, enabling differentiation between changes consistent with natural recovery or standard care and changes potentially attributable to the personalized intervention introduced in Phase B. All clinical activities during this phase are documented in the Electronic Health Record (EHR) to allow retrospective analysis.
Intervention phase (Phase B) During the intervention phase, treatment is continuously adapted to the modifiable biopsychosocial process(es) identified as most relevant, jointly mapped and evaluated with the patient throughout the treatment trajectory. Intervention sequencing is process-driven rather than time-driven. The approach follows five sequential steps: (1) joint identification of modifiable biopsychosocial processes using the Clinical Compass, a structured biopsychosocial anamnesis, and physical examination where relevant; (2) construction of a person-specific network model in which goals, problems, limitations, and influencing factors are represented as interconnected nodes, including feedback loops that may maintain the patient's complaints; (3) shared decision-making to prioritize the most central modifiable process, guided by six criteria (accessibility, centrality, therapist competence, risk, likelihood of change, and strategic positioning); (4) delivery of personalized interventions targeting the selected process, guided by a consensus-based framework linking processes to evidence-based intervention components within the physiotherapy domain, developed through a modified Delphi study among primary care physiotherapy experts; and (5) ongoing monitoring and adjustment, in which each session begins with shared reflection on changes in the targeted process, experiences in daily life, and barriers or facilitators, informing the decision to continue, adapt, or shift the intervention focus.
Treatment duration and frequency are tailored to the individual patient's goals and presenting problems. The intervention concludes once agreed treatment goals are achieved, or if no improvement occurs after six weeks; this decision is explicitly discussed with the patient beforehand. Participants may continue to receive any other usual care they would otherwise receive during the study.
Data collection In parallel with quantitative monitoring, two additional qualitative data sources are collected: semi-structured interviews conducted with participants every three weeks to explore their experienced change and treatment attribution, and session data comprising audio recordings of treatment sessions together with session-level data extracted from the EHR.
Fidelity assessment Intervention fidelity is assessed using three complementary approaches, all based on audio recordings and/or EHR data: (1) a global rating of intervention delivery during the B-phase, based on a purpose-developed rating scale assessing the presence of core PBT elements, the absence of inappropriate elements, and quality of execution; (2) a parallel global rating applied to baseline-phase recordings to confirm the expected absence of PBT-consistent delivery during standard care, supporting intervention differentiation; and (3) a qualitative, deductive analysis of EHR session data examining the sequence, content, and rationale of delivered intervention components, and how these align with patient characteristics and adjustments made over the treatment trajectory. A minimum of 20% of sessions per participant will be reviewed. Two trained raters, blinded to treatment phase, will independently code recordings after a calibration period; inter-rater reliability will be calculated using an intraclass correlation coefficient. Fidelity results are not fed back to physiotherapists during the study.
Data analysis
Quantitative analysis: Individual and cross-participant effects are evaluated using visual analysis (following the Visual Aid Implying an Objective Rule, VAIOR) complemented by multivariate piecewise linear regression, consistent with established SCED analytic approaches. Because the intervention is expected to produce a delayed or progressive rather than immediate effect, visual analysis focuses primarily on the final measurements of the intervention phase. Improvement direction is predefined for each outcome domain prior to analysis. Consistency of effects across the 11 replications is evaluated against a predefined replication criterion (a positive effect in at least 8 of 11 cases). Two trained researchers conduct visual analyses independently, with inter-rater reliability reported.
Participants who complete the baseline phase and at least two weeks of the intervention phase are included in the analysis; missing data are handled using the Expectation-Maximization algorithm.
Sample size was informed by an a priori power analysis for SCED designs, based on a conservative effect size estimate derived from comparable prior research in the same population, and will be re-evaluated after the first five participants.
Qualitative analysis: Interview transcripts are analyzed using descriptive open coding within three predefined analytical domains: experienced change, the relationship between experience and intervention, and the relationship between experience and quantitative measurements. Analysis is conducted independently by two researchers with consensus meetings to resolve differences, supported by peer debriefing from a third researcher not involved in data collection. A narrative pattern description is developed for each participant, and an audit trail and reflexive memos are maintained throughout.
Integration: For each participant, quantitative outcome trajectories (level, trend, and variability) are systematically compared with the qualitative pattern description through triangulation, assessing congruence, divergence, and complementarity to arrive at individual-level meta-inferences.
A cross-case overview subsequently compares all 11 cases on quantitative pattern, experienced trajectory, congruence/divergence, treatment attribution, fidelity scores, and intervention content and sequence, aiming to identify recurring patterns, explanatory variation between cases, and potential subgroups.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- The study will employ a replicated MMSCR with a convergent, parallel, mixed methods approach, in which quantitative and qualitative data will be collected concurrently and subsequently integrated. The quantitative component follows a nonconcurrent AB SCED structure with repeated measurement. Each participant undergoes a baseline phase (A) with standard care, followed by an intervention phase (B) of personalized physiotherapy grounded in a PBT framework. The phase sequence is predetermined: the baseline phase spans three weeks with a minimum of nine measurement points, and the intervention phase lasts at least 2 weeks with a minimum of six measurement points. The number of measurements per phase is based on the required discriminative power to detect changes in the trajectory of outcome variables. Intervention phase duration is patient-dependent; given the target population and average treatment episode length for NSNP, a longer phase is expected.
| Arm | Type | Receives |
|---|---|---|
| Phase A: Baseline conditions | Experimental | Behavioral: Personalized physiotherapy grounded in the PBT frameworkDuring the three-week baseline phase (A), participants will receive standard care, consisting of an intake and two treatment sessions in accordance with the KNGF Clinical Practice Guideline for Neck Pain. Diagnostic procedures will include anamnesis (screening for red flags, classification of neck pain, assessment of symptom characteristics and interference with daily functioning based on the International Classification of Functioning (ICF), as well as symptom course and onset), optionally supplemented with physical examination. Standard care interventions will be delivered according to treatment profile and may include education and advice, mobilizations, and exercise therapy. During the baseline phase, the physiotherapist will deliver usual care without access to the Clinical Compass results and therefore without structured insight into the participant's potentially modifiable biopsychosocial processes targeted in the intervention phase. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age 18 years or older
- New episode of neck pain with duration ≤12 weeks since onset
- Neck pain located in the region shown in Figure 2
- ≥19% risk of developing chronic complaints, as determined using a prognostic model
- If a previous episode of neck pain occurred, the current episode must have been preceded by ≥3 consecutive months without persistent pain (defined as absence of pain associated with activity limitation or healthcare consultation)
Key exclusion criteria (5 listed)
- Prior neck surgery
- Cervical radiculopathy as identified using the Upper Limb Neurodynamic Test (ULNT1)
- Widespread primary pain according to ICD-11 criteria (diffuse musculoskeletal pain in ≥4 of 5 body regions, across ≥3 body quadrants, involving the axial skeleton)
- Pain of non-musculoskeletal origin
- Insufficient proficiency in Dutch to read or understand study instructions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Personalized physiotherapy grounded in the PBT frameworkDuring the intervention phase (B-phase), treatment follows the steps of personalized physiotherapy grounded in a PBT framework. Treatment is continuously adapted to the identified and prioritized modifiable biopsychosocial process, as jointly mapped and evaluated with the patient throughout the treatment trajectory. Intervention sequencing is not time-driven but process-driven, with session-by-session evaluation guiding when to continue, adapt, or shift intervention targets. The identification and ongoing evaluation of relevant processes is informed by the Clinical Compass and, where indicated, supplemented with one or more items from the supplementary item pool. Assessment is guided by a structured biopsychosocial evaluation using the SCEGS framework (Somatic, Cognitive, Emotional, Behavioral, Social), which supports systematic exploration of somatic symptoms, cognitions, emotions, behaviors, and social context to identify modifiable processes. | Behavioural | Phase A: Baseline conditions |
Primary outcome
Pain intensity
Time frame: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Pain intensity will be measured using an 11-point Numeric Pain Rating Scale (NPRS). Patients will answer the question: "How intense was your pain on average over the past two days?" Responses range from 0 = no pain to 10 = worst imaginable pain. The NPRS is a validated instrument recommended in the Royal Dutch Society for Physical Therapy (KNGF) Neck Pain Guideline for evaluating pain intensity. The Minimal Important Change (MIC) for patients with neck pain is 2.5 points.
9 secondary outcomes
Patient-specific activity limitations
Time frame: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Pain coping
Time frame: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Quality of Life as Measured by EQ-5D-VAS
Time frame: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Pain interference
Time frame: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Perceived effect
Time frame: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.
Fear of movement
Time frame: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Hypervigilance
Time frame: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Sleep
Time frame: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Pain catastrophizing
Time frame: Baseline (Week 1), start of intervention phase (Week 4), and post-intervention (study completion, an average of 7 weeks)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jul 2026.
- Project InformationLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. After study completion, de-identified quantitative participant data and associated statistical code will be made available via DataverseNL. Data will be anonymized and reviewed by a data steward prior to sharing, in accordance with FAIR principles and applicable data protection regulations. Access restrictions may apply where necessary to protect participant privacy. Qualitative data (interview transcripts and audio recordings) will not be shared publicly due to the risk of participant re-identification.
Related trials for Precision Medicine
Recruiting
Organoid Drug Sensitivity-Guided Therapy for Refractory Tumors
Refractory Tumors, Organoid
RecruitingPhase 1/2
Precision Microbiota Interventions for Senoreduction Trial
HIV Infections, Alcohol Drinking
Not yet recruitingObservational study
Metabolic Changes in Heart Failure Patients Treated With Vericiguat
Heart Failure, Worsening Heart Failure
Not yet recruiting
Virtual Human Twins as Tools for Personalized Clinical Care in Heart Failure With Preserved Ejection Fraction: a Pilot Study
Heart Failure
Not yet recruitingObservational study
Development and Prospective Validation of the AutoEIT Foundation Model for ARDS
ARDS (Acute Respiratory Distress Syndrome), Respiratory Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Sophie Konings, MSc principal investigator
University of Applied Sciences Utrecht
9 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Personalized physiotherapy grounded in the PBT framework in people with Precision Medicine, run by University of Applied Sciences Utrecht at 9 sites in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 15 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 9 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sophie Konings, MSc (0031638907717, sophie.konings@hu.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain intensity (time frame: Outcomes will be assessed three times per week, from baseline (Week 1) through study completion, an average of 7 weeks.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2026.